Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bio-Techne (TECH) Shares Outstanding (Diluted Average) (2016 - 2021)

Historic Shares Outstanding (Diluted Average) for Bio-Techne (TECH) over the last 9 years, with Q4 2021 value amounting to $41.2 million.

  • Bio-Techne's Shares Outstanding (Diluted Average) rose 235.98% to $41.2 million in Q4 2021 from the same period last year, while for Dec 2021 it was $41.2 million, marking a year-over-year increase of 235.98%. This contributed to the annual value of $40.5 million for FY2021, which is 274.61% up from last year.
  • Bio-Techne's Shares Outstanding (Diluted Average) amounted to $41.2 million in Q4 2021, which was up 235.98% from $41.2 million recorded in Q3 2021.
  • Bio-Techne's 5-year Shares Outstanding (Diluted Average) high stood at $41.2 million for Q4 2021, and its period low was $37.5 million during Q2 2017.
  • Its 5-year average for Shares Outstanding (Diluted Average) is $39.3 million, with a median of $39.3 million in 2019.
  • Per our database at Business Quant, Bio-Techne's Shares Outstanding (Diluted Average) soared by 61.91% in 2017 and then skyrocketed by 314.7% in 2021.
  • Over the past 5 years, Bio-Techne's Shares Outstanding (Diluted Average) (Quarter) stood at $37.9 million in 2017, then increased by 2.17% to $38.7 million in 2018, then rose by 2.07% to $39.6 million in 2019, then grew by 1.79% to $40.3 million in 2020, then rose by 2.36% to $41.2 million in 2021.
  • Its Shares Outstanding (Diluted Average) stands at $41.2 million for Q4 2021, versus $41.2 million for Q3 2021 and $40.5 million for Q2 2021.